Author: admin

Posted on

Opinion: We need more men in nursing

While the number of Americans in need of care keeps rising, many health systems are struggling to find qualified nurses. The demand for qualified nurses is projected to increase nationwide, with nearly 200,000 annual job openings expected. This is driven, in part, by a mass exodus of nurses reaching retirement age. At this critical juncture facing our nation’s health systems, men remain an untapped group whose recruitment into nursing could make a difference.

Even with these persistent and growing nurse workforce shortages, men remain underrepresented in the profession, accounting for just 12% of nurses nationally. Concerted and sustained efforts are urgently needed to recruit more men to join the nursing profession and be positioned to provide high-quality, evidence-based care across communities nationwide.

Read the rest…

Posted on

Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting

In late April, the Centers for Medicare and Medicaid Services and the Food and Drug Administration announced the Regulatory Alignment for Predictable and Immediate Device, or RAPID, coverage pathway. On paper, it is exactly what the medical device community has been asking for: a synchronized process that could deliver Medicare national coverage as soon as two months after FDA market authorization, rather than the year or more families and manufacturers currently endure.

I want this pathway to succeed. I have spent more than a decade helping small companies bring novel devices through FDA review, including several that earned breakthrough device designation. I have watched reimbursement delay strangle technologies that children desperately need. Faster, more predictable coverage is a real problem, and RAPID is a real step.

But this announcement does not fix the way pediatric and orphan devices chronically lag behind their adult counterparts. In some ways, in fact, it deepens that gap.

Continue to STAT+ to read the full story…

Posted on

Why we left the FDA: Six former officials share their stories

A year after U.S. DOGE Service cuts shook up the federal government, STAT’s FDA reporter Lizzy Lawrence has been speaking with former officials about their time at the agency. Two weeks ago, I hit the road with Lizzy to interview six of them about what drew them to the agency, the important work they did during their career there, and, ultimately, why they decided to leave during the second Trump administration. 

In a special road-trip edition of STATus Report, Lizzy and I travel around the leafy suburbs of Washington to bring you first-person testimonies, including the former director of the FDA’s Center for Drug Evaluation and Research, Richard Pazdur; Sheryl Lard-Whiteford, a leader in the FDA’s biologics center; and Julie Tierney, who worked on Operation Warp Speed.

Posted on

Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy

Conditions: Erectile Dysfunction Following Radical Prostatectomy; Prostate Cancer; Urinary Incontinence Following Surgical Procedure

Interventions: Drug: Tadalafil 5 mg; Behavioral: Pelvic Floor Muscle Training (PFMT); Behavioral: Aerobic Exercise Program; Behavioral: Nutritional Recommendations; Behavioral: Psychological and Wellbeing Strategies; Behavioral: Standard Perioperative Care

Sponsors: Surgical Outcomes Research Centre (SOuRCe); Generic Health; National Health and Medical Research Council, Australia; Sydney Local Health District

Not yet recruiting